HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital dyserythropoietic anemia type II: serologic and morphologic family study.

Abstract
A 29-year old woman with a history of chronic anemia, jaundice, and splenectomy was found to have congenital dyserythropoietic anemia type II (CDA II), based on the following: marrow erythroid hyperplasia, abundance of binucleated erythroblasts, electron microscopic evidence of double membranes lining the cell membrane, erythrocyte lysis in the acidified serum test, erythrocyte agglutination and lysis by anti-i antibodies. Three healthy relatives (mother, father, and brother) of the patient had marrow erythroid hyperplasia and a percentage of binucleated erythroblasts that was higher than normal. A structural alteration of the nuclear membrane was detected in some of their erythroblasts. Furthermore, the erythrocytes of the father and the brother were agglutinated by anti-i antibodies. This observation is consistent with a recessive mechanism of inheritance, and suggests that heterozygosity for CDA II can be somatically expressed at different levels.
AuthorsP Ricci, M Baccarani, G Biagini, P Preda, I Tomasini, P Zucchelli, S Tura
JournalNouvelle revue francaise d'hematologie (Nouv Rev Fr Hematol (1978)) Vol. 21 Issue 2 Pg. 197-207 ( 1979) Germany
PMID514807 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bilirubin
Topics
  • Adult
  • Anemia, Dyserythropoietic, Congenital (genetics, immunology, pathology)
  • Anemia, Hemolytic, Congenital (genetics)
  • Bilirubin (blood)
  • Blood Cell Count
  • Bone Marrow (ultrastructure)
  • Child
  • Erythroblasts (ultrastructure)
  • Female
  • Humans
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: